soul trial oral semaglutide cardiovascular outcomes 2024 nejm results Frontiers SOUL: Oral Semaglutide Bests Usual

Dietary modifications represent the cornerstone of symptom management

It is important to note that some cancer treatments, including certain chemotherapy drugs and targeted therapies, may not be a good match with GLP-1 medications

The safety, risk and anticipated benefit of any medication must be measured against the risk of the underlying disease and potential comorbidities that the medication is intended to treat

Additionally, available pharmacological treatments do not target the root causes of the disease or slow down its progression 76

Memory loss is one symptom you dont want to neglect: The neurologic complications of B12 deficiency are often reversible, but not always, warns Green

Secondary outcomes are reported in Table 2